Search
for
Sort by
Research 661–690 of 1000+
- The Rotterdam Study: 2018 update on objectives, design and main results
- Alopecia areata
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Biochemical Testing of the Thyroid: TSH is the Best and, Oftentimes, Only Test Needed – A Review for Primary Care
- Drug-Induced Skin, Nail and Hair Disorders
- Alopecia areata: Clinical presentation, diagnosis, and unusual cases
- Skin biopsy
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Current evaluation of amenorrhea
- 9 Pilosebaceous physiology in relation to hirsutism and acne
- Beyond Expectations
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Anagen effluvium
- Apoptosis and cutaneous biology
- Oral Manifestations of Hematologic and Nutritional Diseases
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- TREATMENT OF ALOPECIA AREATA
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- Endocrine-skin interactions
- Systemic treatments for alopecia areata: A systematic review
- Adrenal Disorders and the Paediatric Brain: Pathophysiological Considerations and Clinical Implications
- Alopecia Areata following Adalimumab
- Current evaluation of amenorrhea
- Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of alopecia areata
- Treatment strategies for alopecia
- Hair loss in children in South-East Nigeria: common and uncommon cases
- Dermatoses of pregnancy
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- A novel therapeutic paradigm for patients with extensive alopecia areata